Botty Investors »

Eliem Therapeutics shares owned by Botty Investors

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Botty Investors from 13F filings

Historical chart of Botty Investors investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Botty Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Botty Investors

Quarter filed Position value Share count Share price at filing
2025-12-31 $486k 121k 4.00

More positions owned by Botty Investors

Alphabet Cap Stk Cl A (GOOGL)
Curtiss-Wright (CW)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Admiral Fds 500 Grth Idx F (VOOG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
La-Z-Boy Incorporated (LZB)
Confluent Class A Com (CFLT)
Dorchester Minerals Com Unit (DMLP)
Ishares Tr Core Msci Eafe (IEFA)
Cisco Systems (CSCO)
Sprott Asset Management Physical Gold Tr (PHYS)
Thermo Fisher Scientific (TMO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Botty Investors

Top funds holding Eliem Therapeutics

RA Capital Management
MPM Oncology Impact Management
ADAR1 Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Dr. Jeffrey R. Jay, M.D.
Sphera Funds Management
Point72 Asset Management
Peapod Lane Capital
Millennium Management
Nan Fung Trinity
Susquehanna International
BlackRock
Renaissance Technologies

View all funds holding Eliem Therapeutics